Stay updated with breaking news from Rhinitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Say: ry-NY-tis Rhinitis is irritation and swelling of the lining of the nose. But you probably just call it a runny nose. You have rhinitis when you have a cold, but allergies to things like pollen from plants and trees also can get your nose running. This is called allergic rhinitis or hay fever. These allergies may make you sneeze or make your eyes water. for Kids
The drug maker announced that its Swiss subsidiary, Glenmark Specialty S.A., received marketing approval from the Ministry of Health of the Russian Federation for Ryaltris nasal spray.Ryaltris (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. Ryaltris relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. This approval paves the way for commercialization of Ryaltris ...
Novel immunotherapy approach to revert the main hallmarks of cat allergy Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analyzed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific i...
Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment Company Prepares for Commercialization of Revolutionary In-Office Therapy Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B financing. The round was led by new investor LSP, from its LSP HEF-2 fund, and co-led by Atlantic Bridge, investing from its Growth Fund IV. Fountain Healthcare Partners also participated as a returning investor with strong participation in the round. The fina...
Treating post-infectious smell loss in COVID-19 patients Thought LeadersProfessor Carl PhilpottAcademic SurgeonUniversity of East Anglia News-Medical catches up with Professor Carl Philpott about the latest findings regarding COVID-19 and smell loss (anosmia), and how sufferers of smell loss post-infection can be treated. We last interviewed you back in the early stages of the COVID pandemic about smell loss and COVID-19, when it was becoming increasingly recognized as an official symptom. How has your research and knowledge developed since then? Firstly, after official recognition by the WHO...